Nonspecificity of p30/32MIC2 Immunolocalization With the 013 Monoclonal Antibody in the Diagnosis of Ewing's Sarcoma: Application of an Algorithmic Immunohistochemical Analysis
- 1 January 1997
- journal article
- Published by Wolters Kluwer Health in Applied Immunohistochemistry & Molecular Morphology
- Vol. 5 (2) , 94-103
- https://doi.org/10.1097/00022744-199706000-00004
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Primary cutaneous neuroendocrine tumorsCancer Genetics and Cytogenetics, 1995
- MAb 013The American Journal of Surgical Pathology, 1995
- MIC2 analysis in pediatric lymphomas and leukemiasHuman Pathology, 1994
- Ewing's sarcoma—Routine diagnostic utilization of MIC2 analysis: A pediatric oncology group/children's cancer group intergroup studyHuman Pathology, 1994
- Immunocytochemical study of 12E7 in small round‐cell tumours of childhood: an assessment of its sensitivity and specificityHistopathology, 1993
- Use of HBA 71 and anti-β2-microglobulin to distinguish peripheral neuroepithelioma from neuroblastomaHuman Pathology, 1993
- The genomic organisation of the human pseudoautosomal gene MIC2 and the detection of a related locusHuman Molecular Genetics, 1993
- Primitive Neuroectodermal Tumor and Ewingʼs SarcomaThe American Journal of Surgical Pathology, 1993
- Comparison of Cell Surface Antigen HBA71 (p30/32MIC2), Neuron-Specific Enolase, and Vimentin in the Immunohistochemical Analysis of Ewingʼs Sarcoma of BoneThe American Journal of Surgical Pathology, 1992
- MIC2 is a specific marker for ewing's sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of ewing's sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberrationCancer, 1991